Todos Medical (TOMDF) News Today → The Worst is Yet to Come… (From Porter & Company) (Ad) Free TOMDF Stock Alerts Add Compare Share Share HeadlinesStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 5, 2024 | morningstar.comTodos Medical Ltd TOMDFDecember 23, 2023 | finanznachrichten.deTodos Medical Ltd.: Todos Medical Announces Insolvency Proceedings in IsraelDecember 22, 2023 | finance.yahoo.comTodos Medical Announces Insolvency Proceedings in IsraelOctober 2, 2023 | investing.comTOMDF Historical DataSeptember 26, 2023 | finance.yahoo.comTodos Medical Provides Corporate Update: Retooling to Focus on Long COVID EpidemicAugust 30, 2023 | finance.yahoo.comTodos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ IngredientsMay 24, 2023 | finance.yahoo.comTodos Medical Ltd. (TOMDF)March 31, 2023 | finance.yahoo.comTodos Medical's Letter of Intent with Provista Diagnostics set to license sepsis diagnostic testingMarch 28, 2023 | proactiveinvestors.comTodos Medical enters LOI for Provista Diagnostics to license key PCR-based sepsis diagnostic testMarch 28, 2023 | finance.yahoo.comTodos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen DiagnosticsMarch 27, 2023 | finance.yahoo.comTodos Medical Begins Trading on the OTC Pink MarketplaceMarch 17, 2023 | proactiveinvestors.comTodos Medical expresses support for Long COVID sufferers, plans to study Tollovid's usefulness in patientsMarch 15, 2023 | finance.yahoo.comTodos Medical Supports Long COVID Awareness DayMarch 13, 2023 | finance.yahoo.comTodos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note HoldersFebruary 24, 2023 | proactiveinvestors.comTodos Medical releases corporate update around validation plan for PCR-based Avian Influenza testingFebruary 23, 2023 | proactiveinvestors.comTodos Medical updates investors on its lab Provista Diagnostics, subsidiary 3CL Pharma, and Todos Botanicals automated retail rolloutFebruary 14, 2023 | proactiveinvestors.comTodos Medical says Provista Diagnostics lab kicks off validation plan for PCR-based bird flu test for humansFebruary 14, 2023 | finance.yahoo.comTodos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista DiagnosticsJanuary 21, 2023 | seekingalpha.comTOMDF Todos Medical Ltd.December 6, 2022 | finance.yahoo.comTodos Medical to Present at the RHK 2022 Disruptive Growth ConferenceNovember 29, 2022 | finance.yahoo.comTodos Medical’s 3CL Pharma Awarded Oral and Poster Presentations at World Antiviral Congress 2022November 22, 2022 | finance.yahoo.comTodos Medical to Attend World Antiviral CongressNovember 16, 2022 | proactiveinvestors.comTodos Medical signs agreement to sell supplements via Affy Services’ Smart Automated Retail NetworkNovember 16, 2022 | finance.yahoo.comTodos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail NetworkNovember 15, 2022 | proactiveinvestors.comTodos Medical on track with Videssa commercialization following eventful third quarterNovember 15, 2022 | finance.yahoo.comTodos Medical Announces Third Quarter 2022 Financial ResultsNovember 15, 2022 | finance.yahoo.comTodos Medical to Host Third Quarter 2022 Earnings and Business Update Conference Call on November 15, 2022November 10, 2022 | finance.yahoo.comTodos Medical Terminates Tollovid™ Products License & Distribution Agreement with T-Cell Protect Hellas S.A.November 4, 2022 | finance.yahoo.comTodos Medical Announces BioFuture™ NYC 2022 PresentationOctober 17, 2022 | proactiveinvestors.comTodos Medical's Provista Diagnostics lab submits emergency use application for PCR monkeypox testOctober 11, 2022 | proactiveinvestors.comTodos Medical eyes NYSE listing as it prepares for 3CL Pharma crowdfunding campaignOctober 11, 2022 | finance.yahoo.comPresenting on the Emerging Growth Conference on October 12 Register NowOctober 6, 2022 | proactiveinvestors.comTodos Medical announces successful pilot launch of suite of PCR testing services by Provista DiagnosticsOctober 6, 2022 | proactiveinvestors.comTodos Medical touts successful pilot launch of suite of PCR testing services by Provista DiagnosticsOctober 6, 2022 | finance.yahoo.comTodos Medical Announces Successful Pilot Launch of Suite of PCR Testing Services by CLIA/CAP Lab Provista DiagnosticsSeptember 30, 2022 | proactiveinvestors.comTodos Medical receives Notices of Allowance for its TBIA pan-cancer blood diagnostics platformSeptember 30, 2022 | finance.yahoo.comTodos Medical Receives Two Notices of Allowance from USPTO for AI-Based TBIA Pan-Cancer Blood Diagnostics PlatformSeptember 27, 2022 | finance.yahoo.comTodos Medical Announces USPTO Trademark Notice of Allowance for 3CL Protease Biomarker Diagnostics TolloTest™September 23, 2022 | finance.yahoo.comTodos Medical Enters Into $50M Contract to Supply Tollovid™ and CBD Products to Retail Distributor Company Nerd HempSeptember 16, 2022 | proactiveinvestors.comTodos Medical announces NFL Hall of Famer Michael Irvin as Tollovid Sports Ambassador for #TolloUp campaignSeptember 16, 2022 | finance.yahoo.comTodos Medical Announces NFL Hall of Famer Michael Irvin as Tollovid™ Sports Ambassador for #TolloUp CampaignSeptember 15, 2022 | finance.yahoo.comTodos Medical Announces Preprint of Long COVID Case Study Participant with Confirmed Microclot and Hyperactivated Platelets who Benefitted from TollovidSeptember 14, 2022 | benzinga.comTodos Medical's 3CL Protease Inhibitor Supplement Tollovid™ Featured in Wellness MagazineSeptember 14, 2022 | finance.yahoo.comTodos Medical Initiates Validation Plan for PCR-based Polio Testing at CLIA/CAP Laboratory Provista DiagnosticsSeptember 13, 2022 | proactiveinvestors.comTodos Medical partner NLC Pharma assigns IP for Tollovir, Tollovid, and TolloTest to 3CL Pharma joint ventureSeptember 13, 2022 | finance.yahoo.comTodos Medical & The Alchemist’s Kitchen to Host “Long COVID: An Integrated Approach” Event Benefitting Survivor CorpsSeptember 12, 2022 | apnews.comTodos Medical Partner NLC Pharma Assigns IP for Tollovir, Tollovid, and TolloTest into JV 3CL PharmaSeptember 12, 2022 | finance.yahoo.comTodos Medical Partner NLC Pharma Assigns IP for Tollovir™, Tollovid™, and TolloTest™ into JV 3CL PharmaSeptember 9, 2022 | finance.yahoo.comTodos Medical CEO Discusses Long COVID Economic Impact with Moneta Advisory Managing Partner Marc LoPrestiSeptember 2, 2022 | finance.yahoo.comTodos Medical Announce Kingcarlx as Brand Ambassador for the Tollovid #TolloUp Lifestyle Campaign Get Todos Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for TOMDF and its competitors with MarketBeat's FREE daily newsletter. Email Address The Worst is Yet to Come… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly. Click here to stream this controversial exposé now. TOMDF Media Mentions By Week TOMDF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TOMDF News Sentiment▼0.000.78▲Average Medical News Sentiment TOMDF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TOMDF Articles This Week▼00▲TOMDF Articles Average Week Get Todos Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for TOMDF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Motus GI News Today Nyxoah News Today Steakholder Foods News Today Stevanato Group News Today Stryker News Today Boston Scientific News Today Becton, Dickinson and Company News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:TOMDF) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThe Only Energy Play You Should Be Looking AtWealthpin Pro[Webinar] Understanding Covered CallsOICWas the Great Financial Crisis fun?Brooks EnterprisesWhat’s Pelosi Buying Now?AltimetryAlex's "Next Magnificent Seven" StocksThe Oxford ClubWrite this ticker symbol down…StocksToTradeClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Todos Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
